Stay updated on Switching to Cabotegravir and Rilpivirine: Clinical Trial
Sign up to get notified when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.
Latest updates to the Switching to Cabotegravir and Rilpivirine: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check15 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference0.5%
- Check22 days agoChange DetectedThe website has updated the citation for the Week 96 extension results of a Phase 3 study on long-acting cabotegravir with rilpivirine for HIV-1 treatment, reflecting a change in authors and the title format.SummaryDifference0.7%
- Check29 days agoChange DetectedSeveral key resources and links related to HIV and clinical studies have been removed, including important URLs from MedlinePlus, PubMed, and ClinicalTrials.gov.SummaryDifference0.9%
- Check36 days agoChange DetectedThe website has been updated to version 2.12.2, adding numerous links to resources related to HIV, clinical studies, and data downloads, while removing the previous version 2.12.1.SummaryDifference1.0%
- Check51 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
Stay in the know with updates to Switching to Cabotegravir and Rilpivirine: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switching to Cabotegravir and Rilpivirine: Clinical Trial page.